VXRT - 3 Long-Shot Coronavirus Vaccine Stocks to Watch in December
Even for people who like to bet on the underdog, it doesn't make much sense to place a bet after the race is over. Now that Moderna and Pfizer have both announced that their coronavirus vaccine candidates appear to be effective at preventing infection, distant laggards look less desirable than ever. That is, until you realize that the coronavirus vaccine race was never a winner-take-all scenario, at least.
Inovio Pharmaceuticals (NASDAQ: INO) , Vaxart (NASDAQ: VXRT) , and Novavax (NASDAQ: NVAX) aren't going to start selling their candidates to the public anytime soon, but they could still be lucrative stocks. All three have moved more slowly than Moderna and Pfizer, but they share one of the same challenges. Much like the two probable victors, each company is relying on a unique and unproven technology or scientific approach to make its vaccine. These technologies could easily make these companies worth betting on -- as long as you're comfortable with a deferred payoff.
Image source: Getty Images.
For further details see:
3 Long-Shot Coronavirus Vaccine Stocks to Watch in December